FDA Agrees With GAO Recommendations To Give Prosecutions Higher Priority

FDA's plans to increase prosecutions of noncompliant food and drug industry officials, as recommended by an internal committee, should include the dietary supplement market, stakeholders say

More from Archive

More from Pink Sheet